clopidogrel acino
acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotična sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
clopidogrel acino pharma
acino pharma gmbh - klopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - clopidogrel je navedeno pri odraslih za preprečevanje atherothrombotic dogodkov v:bolnike, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35 dni), ischaemic kap (od 7 dni do manj kot 6 mesecev) ali sedež periferne arterijske bolezni. za nadaljnje informacije, prosimo, preberite razdelek 5.
clopidogrel acino pharma gmbh
acino pharma gmbh - klopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - clopidogrel je navedeno pri odraslih za preprečevanje atherothrombotic dogodkov v:bolnike, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35 dni), ischaemic kap (od 7 dni do manj kot 6 mesecev) ali sedež periferne arterijske bolezni. za nadaljnje informacije, prosimo, preberite razdelek 5.
buprenorfin acino 35 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 20 mg / 1 obliž - buprenorfin
buprenorfin acino 35 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 20 mg / 1 obliž - buprenorfin
buprenorfin acino 35 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 20 mg / 1 obliž - buprenorfin
buprenorfin acino 35 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 20 mg / 1 obliž - buprenorfin
buprenorfin acino 52,5 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 30 mg / 1 obliž - buprenorfin
buprenorfin acino 52,5 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 30 mg / 1 obliž - buprenorfin
buprenorfin acino 52,5 mikrogramov/uro transdermalni obliži
acino ag - buprenorfin - transdermalni obliž - buprenorfin 30 mg / 1 obliž - buprenorfin